SPS - Specialist Pharmacy Service
The first stop for professional medicines advice
About
Log in
Register
NHS
Guidance
Guidance
Guidance index
COVID-19
PGDs
Administering
Cautions and contraindications
Dosing
Monitoring
Switching
Interactions
Polypharmacy
Safety in breastfeeding
Safety in pregnancy
Temperature management
Excipients
Stability in dosette boxes
Swallowing difficulties
Stability of cytotoxics
Aseptic services
Intrathecal administration
Manufacturing and preparation
Unlicensed medicines
Homecare
ATMPs
Clinical Trials
Medical gases
Search Guidance
Guidance by Care Setting
Adults
Care homes
Care of the elderly
Community Health Services
Dentistry
Emergency medicine and urgent care
Health and Justice
Neonates
Occupational Health
Paediatrics
Palliative and End of Life Care
Primary Care and PCNs
Transfer of care
Trusts
Guidance by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Ear, nose and throat disorders
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Liver disorders
Mental health and illness
Musculo-skeletal disorders
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Public Health
Radiology
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Surgery
Transplantation
Travel Medicine
Vaccinating
Wounds and injuries
Events
Events
Events index
Next events
Past Events
Search Events
Events by Care Setting
Care homes
Care of the elderly
Community Health Services
Health and Justice
Neonates
Paediatrics
Palliative and End of Life Care
Primary Care and PCNs
Transfer of care
Events by Guidance area
Medicines Safety
Patient Group Directions
Regulatory
Safety in Breastfeeding
Safety in Pregnancy
Supply
Events by Specialty
Cardiovascular system disorders
Diabetes
Endocrine system disorders
Gastrointestinal disorders
Infection and infectious diseases
Learning disabilities
Mental health and illness
Respiratory disorders
Planning
Planning
Planning index
Medicines Supply
Annual medicines planning
New Medicines Updates
Biosimilars Updates
Patent Expiry Updates
Search Medicines planning
Planning by Care Setting
Community Health Services
Dentistry
Emergency medicine and urgent care
Health and Justice
Primary Care and PCNs
Transfer of care
Trusts
Planning by Specialty
Allergy and immunology
Anaesthesia and pain
Cancers
Cardiovascular system disorders
Diabetes
Ear, nose and throat disorders
Endocrine system disorders
Eyes and vision
Gastrointestinal disorders
Haematological disorders
Infection and infectious diseases
Liver disorders
Mental health and illness
Musculo-skeletal disorders
Neurological disorders
Nutritional and metabolic disorders
Obstetrics and gynaecology
Public Health
Renal and urologic disorders
Reproductive health
Respiratory disorders
Sexual health
Skin disorders
Stroke
Surgery
Transplantation
Vaccinating
Wounds and injuries
Training
Training
Training index
Courses
Materials
Search Training and Development
Training by Care Setting
Care of the elderly
Community Health Services
Primary Care and PCNs
Transfer of care
Trusts
Training by Specialty
Cardiovascular system disorders
Eyes and vision
Mental health and illness
Reproductive health
Publications
Publications
Publications index
RMOC Recommendations and Resources
Newsletters
Bulletins and summaries
Research and audits
Search Publications
Publications by Care Setting
Care homes
Community Health Services
Emergency medicine and urgent care
Health and Justice
Occupational Health
Primary Care and PCNs
Transfer of care
Trusts
Publications by Specialty
Diabetes
Gastrointestinal disorders
Infection and infectious diseases
Mental health and illness
Musculo-skeletal disorders
Public Health
Radiology
Reproductive health
Sexual health
Skin disorders
Search
Home
Search
Eyes and vision, Medicines planning
94 results
Sort ·
Newest first
Relevance
Newest first
Oldest first
Title
Applied filters
Eyes and vision
Medicines planning
Filter
Guidance
(43)
Advanced therapy medicinal products
(18)
Safety in Breastfeeding
(23)
Stability in dosette boxes
(11)
Temperature management
(11)
Stability outside the fridge
(11)
Medicine
(61)
Aciclovir
(1)
Adalimumab
(1)
Aflibercept
(1)
Apraclonidine
(1)
Atropine
(1)
Azithromycin
(1)
Bevacizumab
(1)
Bimatoprost
(1)
Brimonidine
(1)
Brimonidine + Timolol
(1)
Brinzolamide
(1)
Brinzolamide + Timolol
(1)
Brolucizumab
(1)
Bromfenac
(1)
Ciclosporin
(1)
Ciprofloxacin
(1)
Dexamethasone
(2)
Dorzolamide
(1)
Dorzolamide + Timolol
(1)
Eculizumab
(1)
Fluocinolone acetonide
(1)
Ketorolac
(1)
Latanoprost
(1)
Levobunolol
(1)
Levofloxacin
(1)
Lodoxamide
(1)
Mercaptamine
(1)
Moxifloxacin
(1)
Naphazoline
(1)
Nedocromil
(1)
Nepafenac
(1)
Netilmicin
(2)
Ocriplasmin
(1)
Olopatadine
(1)
Pegaptanib
(1)
Ranibizumab
(4)
Ravulizumab
(1)
Rimexolone
(1)
Sirolimus
(1)
Tafluprost
(1)
Tobramycin
(1)
Travoprost
(1)
Varenicline
(1)
Verteporfin
(1)
Voretigene neparvovec
(1)
Medicines planning
(94)
Biosimilars
(4)
New Medicines
(66)
CCG commissioned new medicines
(42)
NHS England commissioned new medicines
(25)
Pre-registration new medicines (UK/EU)
(9)
Patent expiries
(39)
Specialty
(94)
Allergy and immunology
(2)
Anaesthesia and pain
(2)
Cancers
(5)
Cardiovascular system disorders
(1)
Ear, nose and throat disorders
(1)
Endocrine system disorders
(1)
Eyes and vision
(94)
Gastrointestinal disorders
(1)
Haematological disorders
(4)
Infection and infectious diseases
(6)
Mental health and illness
(1)
Musculo-skeletal disorders
(5)
Nutritional and metabolic disorders
(2)
Public Health
(1)
Respiratory disorders
(2)
Skin disorders
(7)
Omidenepag isopropyl
Preparing to use ranibizumab biosimilar
29 June 2022
·
Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team.
Good governance when implementing ranibizumab biosimilar
29 June 2022
·
Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance.
The licence and supporting evidence for ranibizumab biosimilar
29 June 2022
·
A licensed ranibizumab biosimilar is available from Teva: Ongavia. Learn about the licensed indications and supporting evidence.
ReN003
Lotilaner
EYS606
OPT302
RGX-314
SYD-101
1
2
3
…
10
Next